Skip to main content
Find more clinical trials

Telephone Therapy for Alzheimer's Caregivers

Start: March 24, 2020
End: April 9, 2021
Enrollment: 50

What Is This Study About?

Acceptance and Commitment Therapy (ACT) is a behavioral intervention designed to increase psychological flexibility in the face of challenges. This study will test the effectiveness of a phone-based ACT intervention, called the Telephone Acceptance and Commitment Therapy Intervention for Caregivers (TACTICs), to reduce anxiety and psychological distress in dementia caregivers. Participants will be randomly assigned to receive either six weekly, one-hour telephone-based ACT sessions or minimally enhanced usual care. Researchers will use questionnaires to assess participant levels of anxiety, depression, quality of life, and caregiver burden, at the start of the study and after three and six months.

Do I Qualify To Participate in This Study?

Minimum Age: 21 Years

Maximum Age: N/A

Must have:

  • Able to communicate in English
  • Able to provide informed consent
  • Listed as the primary caregiver in the medical chart of a patient with Alzheimer's disease or a related dementia
  • Self-identifies as the primary caregiver for a person living with Alzheimer's disease or related dementia  
  • Intends to continue caregiving for person living with Alzheimer's disease or related dementia for 12 months
  • Elevated anxiety [score of 10 or higher on Generalized Anxiety Disorder (GAD)-7]

Must NOT have:

  • Not a family member of the person living with Alzheimer's disease or related dementia
  • Caregiver diagnosis of Alzheimer's disease or related dementia, or other serious mental illness diagnosis such as bipolar or schizophrenia, as determined by study sponsor

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Indiana University

Collaborator Sponsor

  • Indiana Clinical and Translational Sciences Institute
  • Regenstrief Institute, Inc.

Source: ClinicalTrials.gov ID: NCT04338750